Abstract
Pancreatic lipase catalyses the hydrolysis of emulsified triglycerides to form a transparent solution of monoglycerides and fatty acids. Levels of serum pancreatic lipase were measured in neonates known to have cystic fibrosis and compared with levels in control infants. During the first weeks of life infants with cystic fibrosis had raised serum pancreatic lipase values in parallel with raised serum trypsin values. A simple and specific turbidimetric dried blood spot assay for serum pancreatic lipase was used as a screening test fo cystic fibrosis in the neonate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adriaenssens K., Janssens H., van Soom H. Two tier screen for cystic fibrosis. Lancet. 1981 Apr 11;1(8224):833–833. doi: 10.1016/s0140-6736(81)92699-4. [DOI] [PubMed] [Google Scholar]
- Borgström A., Sveger T., Lindberg T., Kullander S., Svanberg L. Immunoreactive trypsin, chymotrypsin, and pancreatic secretory trypsin inhibitor in cord blood from infants with cystic fibrosis. Acta Paediatr Scand. 1981 Sep;70(5):619–621. doi: 10.1111/j.1651-2227.1981.tb05756.x. [DOI] [PubMed] [Google Scholar]
- Crossley J. R., Elliott R. B., Smith P. A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979 Mar 3;1(8114):472–474. doi: 10.1016/s0140-6736(79)90825-0. [DOI] [PubMed] [Google Scholar]
- Lebenthal E. Pancreatic function and disease in infancy and childhood. Adv Pediatr. 1978;25:223–261. [PubMed] [Google Scholar]